8-K: Synergy CHC Corp. Faces Nasdaq Non-Compliance Over Delayed Filing

Synergy CHC Corp. received a notice from Nasdaq for non-compliance with listing rules due to its failure to file its Q2 2026 Form 10-Q, with uncertainty surrounding future filings.

Summary

• Synergy CHC Corp. received a notice from Nasdaq on August 20, 2026, indicating non-compliance with Listing Rule 5250(c)(1).
• The non-compliance stems from the failure to file the Quarterly Report on Form 10-Q for the period ended June 30, 2026.
• This notice has no immediate impact on the listing or trading of the company's common stock on Nasdaq.
• The company has 60 days from the notice (until October 19, 2026) to submit a plan of compliance to Nasdaq.
• Nasdaq may grant up to 180 days from the original due date (February 10, 2027) for the company to regain compliance.
• The company cannot predict when, or if, the Q2 Form 10-Q will be filed or if compliance will be regained.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development due to the company's failure to meet Nasdaq's listing requirements and the uncertainty surrounding future filings.

Negatives

• The company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Q2 2026 Form 10-Q.
• There is significant uncertainty regarding the company's ability to file the delayed report and regain compliance with Nasdaq listing rules.
• The company is unable to predict when, or whether, the Q2 Form 10-Q will be filed.

Risks

• Failure to regain compliance with Nasdaq Listing Rule 5250(c)(1) could lead to the delisting of the company's common stock.
• Material delay in financial reporting creates uncertainty for investors.
• Nasdaq may not accept the company's plan of compliance.
• The company may be unable to meet Nasdaq's continued listing requirements.

Future Outlook

The company is unable to predict when, or whether, it will file its Q2 Form 10-Q or regain compliance with Nasdaq listing rules. There can be no assurance that the company will file the Q2 Form 10-Q or otherwise regain compliance.

Management Comments

• "The Notice has no immediate effect on the listing or trading of the Companys common stock on Nasdaq."
• "At this time, the Company is unable to predict when, or whether, the Q2 Form 10-Q will be filed."
• "There can be no assurance that the Company will file the Q2 Form 10-Q or otherwise regain compliance with the Listing Rule."

Industry Context

StockSavvy.ai notes that timely financial reporting is a fundamental requirement for listed companies. Failure to do so, as seen with Synergy CHC Corp., raises significant concerns about operational transparency and financial health, potentially impacting investor confidence across the consumer health and wellness sector.

Stakeholder Impact

• Shareholders: Increased uncertainty regarding the company's financial reporting and continued listing on Nasdaq, potentially leading to share price volatility.
• Creditors: Potential concerns about the company's financial stability and ability to meet reporting obligations.
• Employees: Uncertainty about the company's future operational stability.

Next Steps

• Submit a plan of compliance to Nasdaq by October 19, 2026.
• Regain compliance with Nasdaq Listing Rule 5250(c)(1) by February 10, 2027 (potentially).
• File the Quarterly Report on Form 10-Q for the period ended June 30, 2026.

Key Dates

Recommendation

The company's failure to meet Nasdaq's listing requirements and the significant uncertainty surrounding its ability to file required financial reports indicate severe operational and financial distress. This lack of transparency and potential for delisting presents a substantial risk to investors, warranting a sell recommendation.

Keywords

Nasdaq non-compliance, Delayed filing, Form 10-Q, Listing Rule, Synergy CHC Corp., SEC filing, Consumer health, Wellness products